搜索此博客

2017年7月11日星期二

EOS Med Chem, Medicinal Chemical is Big offers a comprehensive assortment of tubulin inhibitors and DNA-alkylating agents that are proven ADC payloads. Most of these toxins are available in milligram to 100 gram quantities. We also provide linker-drug conjugates in contract synthesis arrangements.  For more information and structures, please visit our website.


ProductCAS No.PurityQuantity available
a-Amanitin>95%mg-g
Auristatin E160800-57-798%mg - 100g
Auristatin F163768-50-198%mg - 100g
Boc-N-Me-Val-Val-Dil-Dap-OH95%mg - kg
Boc-Val-Dil-Dap-Doe95%mg - kg
Boc-Val-Dil-Dap-Nrp95%mg - kg
Boc-Val-Dil-Dap-OH95%mg - kg
Boc-Val-Dil-Dap-Phe-OMe95%mg - kg
Calicheamicin g1108212-75-5>95%mg-100mg
DM1139504-50-098%mg - 100g
DM4799840-96-398%mg - 10g
Dolastatin 1098%mg - 100g
Duocarmycin DM95%mg - g
Duocarmycin MA95%mg - g
Duocarmycin SA95%mg - g
Duocarmycin TM95%mg - g
Epothilone A95%mg – g
HTI-28695%mg - g
Maytansinoid AP-385%mg
Maytansinol95%mg - 100g
Monomethyl Auristatin E474645-27-798%mg - 100g
Monomethyl Auristatin F745017-94-198%mg - 100g
Monomethyl Dolastatin 10203849-91-698%mg - 100g
N-Acetyl-Calicheamicin g1mg-100g
Nemorubicin108852-90-095%mg - 10 g
PBD-dimer>90%mg-100mg
PNU-159682202350-68-3>90%mg -10 g
Triptolide95%mg - g
Tubulysin IM-195%mg - 100g
Tubulysin IM-295%mg - 100g
Tubulysin IM-395%mg - 100g
Tubulysin M205304-86-595%mg - g

EOS Med Chem, Medicinal Chemical is Big offers Safe & Easy Toxin (SET™)

EOS Med Chem, Medicinal Chemical is Big offers Safe & Easy Toxin (SET™), a new research tool for rapid antibody-drug conjugation experiments. SET™s are available for a number of validated linker-toxins and come in small, pre-packaged vials equipped with septum. Each SET™ vial contains approximately 200nmol of linker-toxin, sufficient to conjugate up to 5mg antibody with a drug-to-antibody ratio (DAR) of 3-4. No weighing or aliquoting of the linker-toxin is necessary. Simply follow the dissolution protocol provided with the product and the SET™ is ready to use. The SET™ format is easy to use and, at the same time, minimizes the exposure of the lab space to hazardous toxins. For more information and structures, please visit our website.  Currently, SET™s are available for the following categories. 



Product NameMW
OSu-Glu-vc-PAB-MMAE1334.6
SMCC-DM11072.6
SPDB-DM4780.4
OSu-PEG4-vc-PAB-DMEA-Duocarmycin SA1421.9
Mylotarg-linker1779.7
OSu-Glu-vc-PAB-MMAD1386.7
Sulfo-SPDB-DM41176.8
MC-vc-PAB-MMAE1316.6
MC-MMAF925.2
MC-DM1843.4
MC-MMD-10964.3
MA-PEG4-cv-PAB-DMEA-duocarmycin SA1383.6
MC-cv-PAB-C6-a-amanitin1617
MC-cleavable-linker-a-amanitinProprietary
MC-vc-PAB-DMEA-(PEG2)-duocarmycin SA1253.5
MC-vc-PAB-Tubulysin M1312.6
MC-vc-PAB-Monomethyl-dolastatin101369.7
MA-PEG4-VC-PAB-DMAE-PNU1596821557
MA-PEG4-VA-PBD1294
MC-vc-PAB-MMAF1330.6
MC-vc-PAB-MMAD1369.7
DBCO-PEG4-vc-PAB-MMAE1658.1
DBCO-PEG4-MMAF1252.5
DBCO-PEG4-Ahx-DM11297.9
DBCO-PEG4-vc-PAB-Duocarmycin SA1554
DBCO-PEG4-vc-PAB-(PEG2)-Duocarmycin SA1540
DBCO-PEG4-VA-PBD1430
DBCO-PEG4-vc-PAB-MMAF1672.1
DBCO-PEG4-vc-PAB-MMAD1711.1
Gly3-vc-PAB-MMAE1294.6
Gly3-MMAF903.1
Gly5-Ahx-DM11048.6
PNU159682-EDA-Gly3840.8

Varenicline, world biggest supplier, all from GMP plant

Varenicline, world biggest supplier, all from GMP plant.

Welcome to Site Audit.

Varenicline Impurity we have more than 24.











1) Varenicline of Intermediate -:3-Oxo-1-indanecarboxylic acid  CAS No- 29427-69-8
2) Varenicline of Intermediate-: Methyl 3-Oxo-indan-1-carboxylate  CAS No- 29427-70-1
3) Varenicline of Intermediate-: Methyl 3-cyano-3-[(trimethylsilyl)oxy]-1-indanecarboxylate CAS No- NA
4) Varenicline of Intermediate-: Methyl 3-(aminomethyl)indane-1-carboxylate CAS No- 357426-12-1
5) Varenicline of Intermediate-: 10-Aza-tricyclo[6.3.1.02,7]dodeca-2,4,6-trien-9-one CAS No- NA
6) ) Varenicline of Intermediate-: 10-Aza-tricyclo[6.3.1.0]dodeca-2,4,6-triene CAS No- 69718-72-5
7) ) Varenicline of Intermediate-: 2,3,4,5-Tetrahydro-1,5-methano-1H-3-benzazepine hydrochloride  CAS No- 230615-52-8
8) ) Varenicline of Intermediate-: 1-(10-Aza-tricyclo[6.3.1.0]dodeca-2,4,6-trien-10-yl)-2,2,2-trifluoro-ethanone CAS No- 230615-51-7
9) Varenicline of Intermediate-: 1-(4,5-Diamino-10-aza-tricyclo[6.3.1.0]dodeca-2,4,6-trien-10-yl)-2,2,2-trifluoro-ethanone CAS No- 230615-69-7
10) Varenicline of Intermediate-: Glyoxal sodium bisulfite addition compound hydrate CAS No- 332360-05-1
11) Varenicline of Intermediate-: 2,2,2-Trifluoro-1-(5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaen-14-yl)ethanone CAS No- 230615-70-0
12)Varenicline of Intermediate-: Cyano trimethylsilane  CAS No- 7677-24-9
13)Varenicline of Intermediate-: Trifluoroacetic anhydride  CAS No- 407-25-0
14)Varenicline of Intermediate-: Boron Trifluroride etherate  CAS No- 109-63-7
15)Varenicline of Intermediate-: 1-(4,5-Dinitro-10-aza-tricyclo[6.3.1.0]dodeca-2,4,6-trien-10-yl)-2,2,2-trifluoro-ethanone CAS No- 230615-59-5
16)Varenicline of Intermediate-: Trifluoromethane sulphonic acid  CAS No- 1493-13-6

2017年7月9日星期日

Mirogabalin & Intermediates

Description: Mirogabalin, also known as DS-5565, is an α2δ-1 ligand being developed for pain associated with diabetic peripheral neuropathy, fibromyalgia, and postherpetic neuralgia. Mirogabalin was estimated to be 17-fold more potent than pregabalin. Mirogabalin is being developed by Daiichi Sankyo and related to drugs such as gabapentin and pregabalin. Similarly to these drugs, mirogabalin binds to the α2δ calcium channels (1 and 2), but with significantly higher potency than pregabalin. It has shown promising results in Phase II clinical trials for the treatment of diabetic peripheral neuropathic pain, and is currently in Phase III trials.


Name: Mirogabalin besylate 
CAS#: 1138245-21-2 (besylate) 
Chemical Formula: C18H25NO5S 
Exact Mass: 
Molecular Weight: 367.46 
Elemental Analysis: C, 58.84; H, 6.86; N, 3.81; O, 21.77; S, 8.72


Synonym: DS-5565; DS 5565; DS5565; A-2000700; Mirogabalin; Mirogabalin besylate.
IUPAC/Chemical Name: 2-((1R,5S,6S)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)acetic acid compound with benzenesulfonic acid (1:1)
InChi Key: OKJXJRVWXYRSAN-TXULWXBWSA-N
InChi Code: InChI=1S/C12H19NO2.C6H6O3S/c1-2-8-3-9-5-12(7-13,6-11(14)15)10(9)4-8;7-10(8,9)6-4-2-1-3-5-6/h4,9-10H,2-3,5-7,13H2,1H3,(H,14,15);1-5H,(H,7,8,9)/t9-,10-,12-;/m1./s1
SMILES Code: O=C(O)C[C@]1(CN)[C@]2([H])C=C(CC)C[C@]2([H])C1.O=S(C3=CC=CC=C3)(O)=O



Mirogabalin 1138245-13-21G, CIF, USD 2200/G, IN STOCK
Mirogabalin 1138245-13-25G, CIF, USD 1580/G, IN STOCK
Mirogabalin 1138245-13-210G, CIF, USD 1280/G, IN STOCK
Mirogabalin Intermediate 1235479-61-410G, CIF, USD 6980/10G, 3-4 WEEKS

2017年7月6日星期四

NMR-926265-46-5

We have more than 12kg in stock.

Welcome to ask.


ABT-494, ABT-594 Key Intermediate 1428243-26-8

Good news, after our Lab, hard work more than 3 month.

ABT-494, ABT-594 Key Intermediate 1428243-26-8, we could product batch size more than 1kg, try to be 10kg.

Cut cost of ABT-494, ABT-594, 40%.

Welcome to ask me.

The World first Med Chem the EOS First Supplier of Upadacitinib (of ABT-494) 1310726-60-3.

We Start the this Upadacitinib (of ABT-494) in 1310726-60-3, 2015, an until now, WE Could Supply Upadacitinib (of ABT-494) 1310726-60-3 and Intermediates. Produced total 20 kg.

Upadacitinib (ABT-494) 1310726-60-3, Assay more than 99, HPLC, NMR, MS is provided.

Keep Upadacitinib (ABT-494) 1310726-60-3 100g In stock.

Name: Upadacitinib (ABT-494)
CAS #: 1310726-60-3
Chemical Formula: C17H19F3N6O
Exact Mass: 380.1572
Molecular Weight: 380.3752
Elemental Analysis: C, 53.68; H, 5.04; F, 14.98; N, 22.09; O, 4.21

Now we have all Intermediates & Impurity
Upadacitinib tartrate ABT 494 1607431-21-9 10G IN STOCK, assay 99% in GMP plant, C-GMP standard, now COA, NMR, HPLC, MS is ok.
Upadacitinib ABT 494 1310726-60-3 10G IN STOCK, assay 99% in GMP plant, C-GMP standard, now COA, NMR, HPLC, MS is ok.
Upadacitinib ABT 494 N-1 Intermediates 1428243-28-0 50G IN STOCK, assay 99% in GMP plant, C-GMP standard, now COA, NMR, HPLC, MS is ok.
Upadacitinib ABT 494 N-2 Intermediates 1428243-27-9 50G IN STOCK, assay 99% in GMP plant, C-GMP standard, now COA, NMR, HPLC, MS is ok.
Upadacitinib ABT 494 N-3 Intermediates 1428243-26-8 100G IN STOCK, assay 99% in GMP plant, C-GMP standard, now COA, NMR, HPLC, MS is ok.
Upadacitinib ABT 494 N-4 Intermediates 1201187-44-1 100G IN STOCK, assay 99% in GMP plant, C-GMP standard, now COA, NMR, HPLC, MS is ok.
Upadacitinib ABT 494 N-5 Intermediates 1201186-54-0 100G IN STOCK, assay 99% in GMP plant, C-GMP standard, now COA, NMR, HPLC, MS is ok.
Upadacitinib ABT 494 N-6 Intermediates 875781-41-2 1KG IN STOCK, assay 99% in GMP plant, C-GMP standard, now COA, NMR, HPLC, MS is ok.
Upadacitinib ABT 494 N-7 Intermediates 24241-18-7 1KG IN STOCK, assay 99% in GMP plant, C-GMP standard, now COA, NMR, HPLC, MS is ok.
Upadacitinib ABT 494 N-8 Intermediates 55314-57-3 1KG IN STOCK, assay 99% in GMP plant, C-GMP standard, now COA, NMR, HPLC, MS is ok.

Description: Upadacitinib, also known as ABT-494, is a potent and selective JAK inhibitors in development for rheumatoid arthritis.ABT-494 is approximately 74 fold selection for Jak1 over Jak2 in cellular assays dependent on specific, relevant cytokines. ABT-494 Promising in rat arthritis models. .
the Synonym:.. ABT494; of ABT 494; ABT494 Upadacitinib
the IUPAC / Chemical the Name: (3S, 4R) -3-ethyl-4- (3H-imidazo [1,2-A] pyrrolo [2,3--E] Pyrazin-8-yl) -N- (2,2,2-trifluoroethyl) pyrrolidine-1-carboxamide
SMILES Code: O = C (N1C [C @ H] (CC) [C @ H] (F) (F) F

Appearance: Solid powder
Purity:> 98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non- (1) = C3C = NC (NC = C4) = C4N32) Hazardous chemicalThis product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years) .
Solubility: Soluble in DMSO, in Water Not
Shelf Life:> 2 years Stored Properly IF
Drug Formulation: This Drug On May BE Formulated in DMSO
Stock Solution the Storage: 0 -. 4 C for Short Term (Days to weeks), or -20 C For long term (months).

1: Norman P. Selective JAK inhibitors in development for rheumatoid arthritis.
Expert Opin Investig Drugs. 2014 Aug; 23 (8): 1067-77.
Doi : 10.1517 / 13543784.2014.918604. Epub 2014 May 12 Pub. PubMed PMID: 24818516.Dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). Solubility: Soluble in DMSO, not in water Shelf Life:> 2 years if stored properly Drug Formulation: This Drug may be formulated in DMSO Stock Solution: 0 - 4 C for short term (days to weeks), or -20 C for long term (months). 1: Norman P. Selective JAK inhibitors in development for rheumatoid arthritis. Expert Opin Investig Drugs. 2014 Aug; 23 (8): 1067-77. Doi : 10.1517 / 13543784.2014.918604. Epub 2014 May 12. Review. PubMed PMID: 24818516.Dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). Solubility: Soluble in DMSO, not in water Shelf Life:> 2 years if stored proper Drug Formulation: This Drug may be formulated in DMSO Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months). 1: Norman P. Selective JAK inhibitors in development for rheumatoid arthritis. Expert Opin Investig Drugs. 2014 Aug; 23 (8): 1067-77. Doi : 10.1517 / 13543784.2014.918604. Epub 2014 May 12. Review. PubMed PMID: 24818516.This is may be formulated in DMSO Stock Solution: 0 - 4 C for short term (days to weeks), or -20 C for long term (months). 1: Norman P. Selective JAK inhibitors in development for rheumatoid arthritis. Expert Opinions Investig Drugs. 2014 Aug; 23 (8): 1067-77. Doi : 10.1517 / 13543784.2014.918604. Epub 2014 May 12. Review. PubMed PMID: 24818516.This is may be formulated in DMSO Stock Solution: 0 - 4 C for short term (days to weeks), or -20 C for long term (months). 1: Norman P. Selective JAK inhibitors in development for rheumatoid arthritis. Expert Opinions Investig Drugs. 2014 Aug; 23 (8): 1067-77. Doi : 10.1517 / 13543784.2014.918604. Epub 2014 May 12. Review. PubMed PMID: 24818516.